Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03629197 · ClinicalTrials.gov registry record · NA

Improving Communication About Pain and Opioids

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT03629197 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03629197, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The overall goal of this protocol is to pilot test a clinician training intervention that uses standardized patients (trained actors playing patient roles) as instructors who impart communication skills to primary care clinicians. This project will conduct a pilot clinical trial of the intervention developed by the primary investigator in order to evaluate intervention feasibility and generate data to plan a subsequent fully-powered, multisite trial. Primary care clinicians will be randomized to receive either the intervention or control; 48 patients (2 per clinician) will then be recorded during clinic visits with study clinicians and will provide data on post-visit perceptions and health outcomes. Study hypotheses are that visits with clinicians who receive the intervention (versus control) will be associated with more frequent use of targeted communication skills, lower probability of high-risk opioid prescribing, higher patient-reported agreement with treatment plan, and lower pain interference 2 months later.

Interventions

  • OTHER Attention control
  • BEHAVIORAL Communication skills training

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2017-10-31
Est. Completion 2020-08-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03629197

The ClinicalTrials.gov registry entry for NCT03629197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.

NCT03629197 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03629197 about?

NCT03629197 is a clinical study titled "Improving Communication About Pain and Opioids". The overall goal of this protocol is to pilot test a clinician training intervention that uses standardized patients (trained actors playing patient roles) as instructors who impart communication skills to primary care clinicians. This project will conduct a pilot clinical trial of the intervention ...

What is the current status of trial NCT03629197?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2017-10-31. Estimated completion is 2020-08-31.

What interventions are being tested in trial NCT03629197?

The interventions under investigation include: Attention control (OTHER), Communication skills training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03629197?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.